BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 17978814)

  • 1. The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane.
    Huls M; Brown CD; Windass AS; Sayer R; van den Heuvel JJ; Heemskerk S; Russel FG; Masereeuw R
    Kidney Int; 2008 Jan; 73(2):220-5. PubMed ID: 17978814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel understanding of ABC transporters ABCB1/MDR/P-glycoprotein, ABCC2/MRP2, and ABCG2/BCRP in colorectal pathophysiology.
    Andersen V; Svenningsen K; Knudsen LA; Hansen AK; Holmskov U; Stensballe A; Vogel U
    World J Gastroenterol; 2015 Nov; 21(41):11862-76. PubMed ID: 26557010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
    Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
    Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one).
    Mizuno N; Takahashi T; Kusuhara H; Schuetz JD; Niwa T; Sugiyama Y
    Drug Metab Dispos; 2007 Nov; 35(11):2045-52. PubMed ID: 17682070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense.
    Leslie EM; Deeley RG; Cole SP
    Toxicol Appl Pharmacol; 2005 May; 204(3):216-37. PubMed ID: 15845415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ABC transporter expression profiling after ischemic reperfusion injury in mouse kidney.
    Huls M; van den Heuvel JJ; Dijkman HB; Russel FG; Masereeuw R
    Kidney Int; 2006 Jun; 69(12):2186-93. PubMed ID: 16612327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the breast cancer resistance protein (ABCG2) in drug transport.
    Mao Q; Unadkat JD
    AAPS J; 2005 May; 7(1):E118-33. PubMed ID: 16146333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gender differences in mRNA expression of ATP-binding cassette efflux and bile acid transporters in kidney, liver, and intestine of 5/6 nephrectomized rats.
    Lu H; Klaassen C
    Drug Metab Dispos; 2008 Jan; 36(1):16-23. PubMed ID: 17855625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing the breast cancer resistance protein expression and function in caco-2 cells using lentiviral vector-based short hairpin RNA.
    Zhang W; Li J; Allen SM; Weiskircher EA; Huang Y; George RA; Fong RG; Owen A; Hidalgo IJ
    Drug Metab Dispos; 2009 Apr; 37(4):737-44. PubMed ID: 19131524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the drug transporters MDR1/ABCB1, MRP1/ABCC1, MRP2/ABCC2, BCRP/ABCG2, and PXR in peripheral blood mononuclear cells and their relationship with the expression in intestine and liver.
    Albermann N; Schmitz-Winnenthal FH; Z'graggen K; Volk C; Hoffmann MM; Haefeli WE; Weiss J
    Biochem Pharmacol; 2005 Sep; 70(6):949-58. PubMed ID: 16054595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer resistance protein (BCRP/MXR/ABCG2) in acute myeloid leukemia: discordance between expression and function.
    Suvannasankha A; Minderman H; O'Loughlin KL; Nakanishi T; Greco WR; Ross DD; Baer MR
    Leukemia; 2004 Jul; 18(7):1252-7. PubMed ID: 15208643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of diclofenac by breast cancer resistance protein (ABCG2) and stimulation of multidrug resistance protein 2 (ABCC2)-mediated drug transport by diclofenac and benzbromarone.
    Lagas JS; van der Kruijssen CM; van de Wetering K; Beijnen JH; Schinkel AH
    Drug Metab Dispos; 2009 Jan; 37(1):129-36. PubMed ID: 18845662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract.
    Gutmann H; Hruz P; Zimmermann C; Beglinger C; Drewe J
    Biochem Pharmacol; 2005 Sep; 70(5):695-9. PubMed ID: 15998509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluorescence-Based Transport Assays Revisited in a Human Renal Proximal Tubule Cell Line.
    Caetano-Pinto P; Janssen MJ; Gijzen L; Verscheijden L; Wilmer MJ; Masereeuw R
    Mol Pharm; 2016 Mar; 13(3):933-44. PubMed ID: 26871298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis.
    Ifergan I; Shafran A; Jansen G; Hooijberg JH; Scheffer GL; Assaraf YG
    J Biol Chem; 2004 Jun; 279(24):25527-34. PubMed ID: 15047700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-activity p-glycoprotein, multidrug resistance protein 2, and breast cancer resistance protein membrane vesicles prepared from transiently transfected human embryonic kidney 293-epstein-barr virus nuclear antigen cells.
    Karlsson JE; Heddle C; Rozkov A; Rotticci-Mulder J; Tuvesson O; Hilgendorf C; Andersson TB
    Drug Metab Dispos; 2010 Apr; 38(4):705-14. PubMed ID: 20071452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport of anthelmintic benzimidazole drugs by breast cancer resistance protein (BCRP/ABCG2).
    Merino G; Jonker JW; Wagenaar E; Pulido MM; Molina AJ; Alvarez AI; Schinkel AH
    Drug Metab Dispos; 2005 May; 33(5):614-8. PubMed ID: 15703302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
    Mizuarai S; Aozasa N; Kotani H
    Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2.
    Lepper ER; Nooter K; Verweij J; Acharya MR; Figg WD; Sparreboom A
    Pharmacogenomics; 2005 Mar; 6(2):115-38. PubMed ID: 15882131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule.
    Jenkinson SE; Chung GW; van Loon E; Bakar NS; Dalzell AM; Brown CD
    Pflugers Arch; 2012 Dec; 464(6):601-11. PubMed ID: 23014881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.